Inappropriate dose of direct oral anticoagulants therapy in patients with non-valvular atrial fibrillation

被引：0
|
作者：
Ito, M. [1 ]
Kaikita, K. [1 ]
Sueta, D. [1 ]
Ishii, M. [1 ]
Oimatsu, Y. [1 ]
Mitsuse, T. [1 ]
Arima, Y. [1 ]
Iwashita, S. [1 ]
Takahashi, A. [1 ]
Kanazawa, H. [1 ]
Kaneko, S. [1 ]
Kanemaru, Y. [1 ]
Kiyama, T. [1 ]
Yamabe, H. [1 ]
Tsujita, K. [1 ]
机构：
[1] Kumamoto Univ, Kumamoto Univ Hosp, Dept Cardiovasc Med, Grad Sch Med Sci, Kumamoto, Japan
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2504
引用
收藏
页码：485 / 486
页数：2
相关论文
共 50 条
  • [21] Reasons for discontinuation of direct oral anticoagulant therapy in patients with non-valvular atrial fibrillation
    Renner, Elizabeth
    Mouland, Erin
    Saad, Samira
    Ha, Nghi
    Kim, Pauline
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (04) : 617 - 618
  • [22] Quality of direct oral anticoagulant therapy in elderly patients with non-valvular atrial fibrillation
    Agirbasli, Mehmet
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 46 (04) : 570 - 570
  • [23] Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non-valvular atrial fibrillation
    Thomsen, T. Alvaro
    Guadalupe, J. Mesa
    Huerta, C.
    de Burgos, A.
    Soriano, L. Cea
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [24] Direct Oral Anticoagulants and Non-valvular Atrial Fibrillation: Compliance with Dose Level Guidelines in Patients Aged 80 Years and Over
    Marie Cavillon Decaestecker
    Laurie Ferret
    Kevin Decaestecker
    Sophie Gautier
    Stéphane Verdun
    Essé Sylvestre Tsogli
    Drugs & Aging, 2021, 38 : 939 - 950
  • [25] Direct oral anticoagulants in patients with cardiac implantable devices and non-valvular atrial fibrillation: the complexity of dose adjustments and the impact on outcomes
    Santos, J. M.
    Mendes, A. R.
    Rocha, M. J.
    Goncalves, L.
    Antonio, N.
    Fortuna, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 : 47 - 47
  • [26] Direct oral anticoagulants (doacs) use in patients with cardiac implantable devices and non-valvular atrial fibrillation: the complexity of dose adjustments
    Santos, J.
    Mendes, A. R.
    Silva, R.
    Antonio, N.
    Rocha, M.
    Fortuna, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 268 - 268
  • [27] Direct Oral Anticoagulants and Non-valvular Atrial Fibrillation: Compliance with Dose Level Guidelines in Patients Aged 80 Years and Over
    Decaestecker, Marie Cavillon
    Ferret, Laurie
    Decaestecker, Kevin
    Gautier, Sophie
    Verdun, Stephane
    Tsogli, Esse Sylvestre
    DRUGS & AGING, 2021, 38 (10) : 939 - 950
  • [28] Novel Anticoagulants for Non-valvular Atrial Fibrillation
    Xu, Bo
    Whitbourn, Robert
    HEART LUNG AND CIRCULATION, 2012, 21 (08): : 463 - 467
  • [29] Newer Anticoagulants for Non-Valvular Atrial Fibrillation
    Harburger, Joseph M.
    Aronow, Wilbert S.
    PHARMACEUTICALS, 2012, 5 (05) : 469 - 480
  • [30] Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation
    Halperin, Jonathan L.
    Dorian, Paul
    CURRENT CARDIOLOGY REVIEWS, 2014, 10 (04) : 297 - 302
12345